Acitretin combination therapy - 07/09/11
Abstract |
Systemic therapies used in psoriasis such as methotrexate, PUVA, cyclosporine, and acitretin often have side effects that limit their usefulness. Combination therapy, an effective strategy for treating psoriasis, allows use of lower doses of medications to achieve superior therapeutic results with fewer side effects. Acitretin is one of the most popular drugs used in combination with other systemic therapies for psoriasis. Details of the regimens used and results obtained from combining acitretin with PUVA, cyclosporine, and methotrexate are discussed. (J Am Acad Dermatol 1999;41:S18-21.)
Il testo completo di questo articolo è disponibile in PDF.Mappa
 | From Arizona Advanced Dermatology, Phoenix, and Northwestern University Medical School, Chicago. |
| This manuscript is based on a presentation given at the 5th European Congress on Psoriasis/7th International Psoriasis Symposium in Milan, Italy on September 2, 1998, with support from Roche Laboratories, Inc., Nutley, NJ. |
 | Reprint requests: Henry H. Roenigk, Jr, MD, Arizona Advanced Dermatology, 500 W Thomas Road, Suite 360, Phoenix, AZ 85013. |
| 0190-9622/99/$8.00 + 0 16/0/100480 |
Vol 41 - N° 3S
P. S18-S21 - settembre 1999 Ritorno al numero
Articolo precedente
- Acitretin: Optimal dosing strategies
- Mark R. Ling
- Acitretin in combination with UVB or PUVA
- Mark Lebwohl
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?